Omass (AgeTech UK) Biomed
High-res Mass Spec drug discovery: G-protein receptor, immuno-dysregulation, protein-protein interactions.
Technology:
AgeTech Companies
Headquarters:
United Kingdom
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
N/A
Number Of Exists:
N/A
Employee Number:
N/A
Industry:
UK AgeTech 2020
Investor Type:
N/A